Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Development of vaccines against meningococcal disease.

Jódar L, Feavers IM, Salisbury D, Granoff DM.

Lancet. 2002 Apr 27;359(9316):1499-508. Review.

PMID:
11988262
2.
3.

Meningococcal disease: a review on available vaccines and vaccines in development.

Bröker M, Fantoni S.

Minerva Med. 2007 Oct;98(5):575-89. Review.

PMID:
18043565
5.

Postgenomics of Neisseria meningitidis for vaccines development.

Bernardini G, Braconi D, Martelli P, Santucci A.

Expert Rev Proteomics. 2007 Oct;4(5):667-77. Review.

PMID:
17941821
6.

Vaccines against meningococcal disease: current and future technologies.

Riddell A, Buttery J.

Expert Opin Biol Ther. 2001 May;1(3):385-99. Review.

PMID:
11727513
7.

Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005.

Harrison LH, Shutt KA, Schmink SE, Marsh JW, Harcourt BH, Wang X, Whitney AM, Stephens DS, Cohn AA, Messonnier NE, Mayer LW.

J Infect Dis. 2010 Apr 15;201(8):1208-24. doi: 10.1086/651505.

8.

[Meningococcal vaccines: present status and perspectives].

Alonso JM, Taha MK.

Therapie. 2005 May-Jun;60(3):283-6. Review. French.

PMID:
16128272
9.

Vaccine development against Neisseria meningitidis.

Vogel U, Claus H.

Microb Biotechnol. 2011 Jan;4(1):20-31. doi: 10.1111/j.1751-7915.2010.00178.x. Review.

10.

Meningococcal vaccine development--from glycoconjugates against MenACWY to proteins against MenB--potential for broad protection against meningococcal disease.

Dull PM, McIntosh ED.

Vaccine. 2012 May 30;30 Suppl 2:B18-25. doi: 10.1016/j.vaccine.2012.01.062. Review.

PMID:
22607895
11.

Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease.

McNeil LK, Zagursky RJ, Lin SL, Murphy E, Zlotnick GW, Hoiseth SK, Jansen KU, Anderson AS.

Microbiol Mol Biol Rev. 2013 Jun;77(2):234-52. doi: 10.1128/MMBR.00056-12. Review.

12.

Reverse vaccinology--in search of a genome-derived meningococcal vaccine.

Danzig L.

Vaccine. 2006 Apr 12;24 Suppl 2:S2-11-2. Review.

PMID:
16823908
13.

Meningococcal vaccines.

Danzig L.

Pediatr Infect Dis J. 2004 Dec;23(12 Suppl):S285-92. Review.

PMID:
15597071
14.

Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.

Trotter CL, Ramsay ME.

FEMS Microbiol Rev. 2007 Jan;31(1):101-7. Epub 2006 Dec 1.

15.

Meningococcal vaccines.

Rosenstein NE, Fischer M, Tappero JW.

Infect Dis Clin North Am. 2001 Mar;15(1):155-69. Review.

PMID:
11301813
16.

Development of new vaccines against meningococcal disease.

Bröker M.

Arzneimittelforschung. 2003;53(12):805-13. Review.

PMID:
14732960
17.

Prospects for vaccine prevention of meningococcal infection.

Harrison LH.

Clin Microbiol Rev. 2006 Jan;19(1):142-64. Review.

18.

Meningococcal vaccine evolution.

Bona G, Guidi C.

J Prev Med Hyg. 2012 Sep;53(3):131-5.

PMID:
23362617
19.

Serogroup B meningococcal vaccines.

Zimmer SM, Stephens DS.

Curr Opin Investig Drugs. 2006 Aug;7(8):733-9. Review.

PMID:
16955685
20.

[Meningococcal vaccines: from polysaccharide to conjugate vaccines].

Cohen R, Levy C.

Arch Pediatr. 2012 Sep;19 Suppl 2:S61-4. doi: 10.1016/S0929-693X(12)71275-7. French.

PMID:
22883368
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk